To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


View sample alert

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Select Committee
Royal Pharmaceutical Society
NHL0086 - NHS leadership, performance and patient safety

Written Evidence Apr. 24 2024

Inquiry: NHS leadership, performance and patient safety
Inquiry Status: Closed
Committee: Health and Social Care Committee (Department: Department of Health and Social Care)

Found: Pharmacy system leadership 2.Pharmacists play a vital role in supporting medicines optimisation –


Select Committee
Healthcare Services Safety Investigation Body
NHL0022 - NHS leadership, performance and patient safety

Written Evidence Apr. 24 2024

Inquiry: NHS leadership, performance and patient safety
Inquiry Status: Closed
Committee: Health and Social Care Committee (Department: Department of Health and Social Care)

Found: We note that primary care providers (including dentists and community pharmacy) are not included in


Petitions
Access to GP appointments - Wed 24 Apr 2024
No Department present

Mentions:
1: None This includes an additional 36,523 direct patient care staff, such as pharmacy technicians and physician - Speech Link
2: None We have also expanded community pharmacy, with the introduction of Pharmacy First, underpinned by £645 - Speech Link


Select Committee
Twenty-Eighth Report - Student loans issued to those studying at franchised higher education providers

Report Apr. 24 2024

Committee: Public Accounts Committee

Found: State Pension HC 654 34th Local Government Finance System: Overview and Challenges HC 646 35th The pharmacy


Non-Departmental Publication (News and Communications)
Medicines and Healthcare products Regulatory Agency

Apr. 23 2024

Source Page: Class 3 Medicines Recall: Neon Healthcare Ltd, Suprefact 1 mg/ml solution for injection (Cheplapharm – Canadian Livery), EL(24)A/14
Document: Class 3 Medicines Recall: Neon Healthcare Ltd, Suprefact 1 mg/ml solution for injection (Cheplapharm – Canadian Livery), EL(24)A/14 (PDF)

Found: Page 1 of 2 M E D I C I N E S R E C A L L CLASS 3 MEDICINES RECALL Action Within 5 Days Pharmacy


Scottish Government Publication (Speech/statement)

Apr. 23 2024

Source Page: Cass Review and Gender Identity Healthcare
Document: Cass Review and Gender Identity Healthcare (webpage)

Found: team within the Office of the Chief Medical Officer in the Scottish Government, including paediatric, pharmacy


Commons Chamber
Oral Answers to Questions - Tue 23 Apr 2024
Department of Health and Social Care

Mentions:
1: Andrew Stephenson (Con - Pendle) We need to continue to work with programmes such as Pharmacy First, and we are taking other steps to - Speech Link
2: Andrea Leadsom (Con - South Northamptonshire) that the actual resources in GP practice are increasing, with specialisms such as physiotherapy and pharmacy - Speech Link
3: Andrea Leadsom (Con - South Northamptonshire) Our primary care recovery plan enhances GP access by expanding community pharmacy services nationwide - Speech Link
4: Kerry McCarthy (Lab - Bristol East) in Fishponds have been told that it is over an hour’s wait for prescription medication at the local pharmacy—and - Speech Link


Scottish Parliament Debate - Main Chamber
Gender-identity Healthcare for Young People - Tue 23 Apr 2024

Mentions:
1: Minto, Jenni (SNP - Argyll and Bute) the office of the chief medical officer in the Scottish Government—including people with paediatric, pharmacy - Speech Link


Written Question
Pharmacy: Living Wage
Tuesday 23rd April 2024

Asked by: Rachael Maskell (Labour (Co-op) - York Central)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential impact of the new Living Wage rate on community pharmacies.

Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)

Pharmacy First was launched on 31 January 2024, and as the service embeds, we will monitor and evaluate the service and keep the conditions covered by Pharmacy First under review, but it is too early to consider expanding the clinical pathways.

In the Delivery plan for recovering access to primary care, we estimated that Pharmacy First, together with the expanded blood pressure check and contraception service, once fully scaled, could remove up to 10 million general practice (GP) appointments. We are monitoring the number of Pharmacy First consultations in community pharmacy but it is not possible to monitor the number of GP appointments Pharmacy First frees up. However, we know that Pharmacy First will enable GPs to see patients with more complex needs quicker.

Since 2019, GPs and their teams have already been referring patients to community pharmacies for minor illnesses and Pharmacy First builds on this. NHS England has engaged with GPs during the development and launch of Pharmacy First and Community Pharmacy England has launched a dedicated website for GPs supporting them with Pharmacy First referrals.

Pharmacies are not paid an establishment grant. Contractors who have signed up to deliver Pharmacy First received a £2,000 set-up fee, they receive £15 per consultation and £1,000 for each month they reach an agreed minimum number of consultations. Funding for community pharmacies, including the funding for Pharmacy First, is expected to pay for all their costs in providing the service. There are no delays to Pharmacy First payments. All payments are made in line with the usual schedule of payments.

The statutory National Minimum Wage and National Living Wage is based on advice of the Low Pay Commission, which takes into account the impact on business and the wider economy, as well as the living standards of workers.


Written Question
Pharmacy
Tuesday 23rd April 2024

Asked by: Rachael Maskell (Labour (Co-op) - York Central)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps she is taking to tackle delays to payments to community pharmacies operating Pharmacy First.

Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)

Pharmacy First was launched on 31 January 2024, and as the service embeds, we will monitor and evaluate the service and keep the conditions covered by Pharmacy First under review, but it is too early to consider expanding the clinical pathways.

In the Delivery plan for recovering access to primary care, we estimated that Pharmacy First, together with the expanded blood pressure check and contraception service, once fully scaled, could remove up to 10 million general practice (GP) appointments. We are monitoring the number of Pharmacy First consultations in community pharmacy but it is not possible to monitor the number of GP appointments Pharmacy First frees up. However, we know that Pharmacy First will enable GPs to see patients with more complex needs quicker.

Since 2019, GPs and their teams have already been referring patients to community pharmacies for minor illnesses and Pharmacy First builds on this. NHS England has engaged with GPs during the development and launch of Pharmacy First and Community Pharmacy England has launched a dedicated website for GPs supporting them with Pharmacy First referrals.

Pharmacies are not paid an establishment grant. Contractors who have signed up to deliver Pharmacy First received a £2,000 set-up fee, they receive £15 per consultation and £1,000 for each month they reach an agreed minimum number of consultations. Funding for community pharmacies, including the funding for Pharmacy First, is expected to pay for all their costs in providing the service. There are no delays to Pharmacy First payments. All payments are made in line with the usual schedule of payments.

The statutory National Minimum Wage and National Living Wage is based on advice of the Low Pay Commission, which takes into account the impact on business and the wider economy, as well as the living standards of workers.